Qiming U.S. Ventures Management
Latest statistics and disclosures from Qiming U.S. Ventures Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Icosavax, KRRO, TRML, HLVX, Jasper Therapeutics, and represent 96.56% of Qiming U.S. Ventures Management's stock portfolio.
- Added to shares of these 2 stocks: KRRO (+$18M), TRML (+$17M).
- Started 2 new stock positions in TRML, KRRO.
- Reduced shares in these 1 stock: Talaris Therapeutics (-$8.2M).
- Sold out of its position in Talaris Therapeutics.
- Qiming U.S. Ventures Management was a net buyer of stock by $26M.
- Qiming U.S. Ventures Management has $109M in assets under management (AUM), dropping by 44.99%.
- Central Index Key (CIK): 0001909617
Tip: Access up to 7 years of quarterly data
Positions held by Qiming U.S. Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 8 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Icosavax | 50.7 | $55M | 3.5M | 15.76 |
|
|
Korro Bio (KRRO) | 16.2 | $18M | NEW | 368k | 47.93 |
|
Tourmaline Bio (TRML) | 15.4 | $17M | NEW | 642k | 26.18 |
|
Hillevax (HLVX) | 8.2 | $9.0M | 559k | 16.05 |
|
|
Jasper Therapeutics | 6.2 | $6.7M | 8.5M | 0.79 |
|
|
Ventyx Biosciences (VTYX) | 1.6 | $1.7M | 686k | 2.47 |
|
|
Elevation Oncology (ELEV) | 1.2 | $1.3M | 2.4M | 0.54 |
|
|
Kezar Life Sciences (KZR) | 0.7 | $785k | 829k | 0.95 |
|
Past Filings by Qiming U.S. Ventures Management
SEC 13F filings are viewable for Qiming U.S. Ventures Management going back to 2021
- Qiming U.S. Ventures Management 2023 Q4 filed Feb. 14, 2024
- Qiming U.S. Ventures Management 2023 Q3 filed Nov. 9, 2023
- Qiming U.S. Ventures Management 2023 Q2 filed July 24, 2023
- Qiming U.S. Ventures Management 2023 Q1 filed April 25, 2023
- Qiming U.S. Ventures Management 2022 Q4 filed Jan. 24, 2023
- Qiming U.S. Ventures Management 2022 Q3 filed Nov. 8, 2022
- Qiming U.S. Ventures Management 2022 Q2 filed July 22, 2022
- Qiming U.S. Ventures Management 2022 Q1 filed May 16, 2022
- Qiming U.S. Ventures Management 2021 Q4 filed Feb. 14, 2022